{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:04:26Z","timestamp":1761512666050},"reference-count":6,"publisher":"BMJ","issue":"6583","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1987,5,23]]},"DOI":"10.1136\/bmj.294.6583.1323-a","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T19:19:55Z","timestamp":1238699995000},"page":"1323-1324","source":"Crossref","is-referenced-by-count":10,"title":["Clinical evaluation of lysuride in the management of hyperprolactinaemia."],"prefix":"10.1136","volume":"294","author":[{"given":"P M","family":"Bouloux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Besser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"Moult","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem-53-4-737","article-title":"Size reduction of macroprolactinomas by bromocriptine or lisuride treatment","volume":"53","author":"Chiodini, P.; Liuzzi, A.; Cozzi, R.","year":"1981","unstructured":"Chiodini P, Liuzzi A, Cozzi R, et al. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.J Clin Endocrinol Metab 1981;53:737-43.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2265.1985.tb02996.x","article-title":"A comparison of the endocrine profiles and clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia","volume":"22","author":"Grossman, A.; Bouloux, P.; Loneragan, R.; tees LH; Wass, J.A.H.; Besser, G.M.","year":"1985","unstructured":"Grossman A, Bouloux P, Loneragan R, tees LH, Wass JAH, Besser GM. A comparison of the endocrine profiles and clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia. Clin Endoctinol 1985;22:611-6.","journal-title":"Clin Endoctinol"},{"key":"ref_3","first-page":"1783","article-title":"Intolerance of bromocriptine: is metergoline a satisfactory alternative?","volume":"290","author":"Casson, I.F.; Walker, B.A.; Hipkin, U.J.; Belchetz, P.E.","year":"1985","unstructured":"Casson IF, Walker BA, Hipkin UJ, Belchetz PE. Intolerance of bromocriptine: is metergoline a satisfactory alternative? BrMedJ 1985;290:1783-4.","journal-title":"BrMedJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1530\/acta.0.1110460","article-title":"Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride","volume":"111","author":"Graf, K.J.; Horowski, R.; Dorow, R.","year":"1986","unstructured":"Graf KJ, Horowski R, Dorow R. Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride. Acta Endocrinol 1986;111:460-6.","journal-title":"Acta Endocrinol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(87)91906-4","article-title":"Jakobson 5, Akcerstrom G, Ljunghail S. Survival and renal function in untreated hypeccalcaemia","volume":"i:","author":"Palmer, M.; Adamin, H.; Bergstrom, R.","year":"1987","unstructured":"Palmer M, Adamin H, Bergstrom R, Jakobson 5, Akcerstrom G, Ljunghail S. Survival and renal function in untreated hypeccalcaemia. Lancet 1987,i:59-62.","journal-title":"Lancet"},{"issue":"74","key":"ref_6","first-page":"507","article-title":"Diatribution of serum calciumQ and phosphorus values iQ unselected amnbulatory patients","volume":"1969","author":"Kesting, F.R.; Jones, J.D.; Elvebach, L.R.","unstructured":"Kesting FR, Jones JD, Elvebach LR. Diatribution of serum calciumQ and phosphorus values iQ unselected amnbulatory patients.JyLab ClinMesd 1969;74:507-14.","journal-title":"JyLab ClinMesd"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.294.6583.1323-a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T20:37:44Z","timestamp":1601066264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.294.6583.1323-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,5,23]]},"references-count":6,"journal-issue":{"issue":"6583","published-print":{"date-parts":[[1987,5,23]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.294.6583.1323-a","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,5,23]]}}}